A novel human Streptomyces strain redresses malignancy by inducing apoptosis and regaining gut homeostasis.

A novel human gut-derived Streptomyces strain, CGMCC 17111, exhibits potent suppressive effects on colorectal cancer without causing inflammatory reactions.

• Why it matters: Colorectal cancer remains highly deadly with limited effective treatments due to drug resistance and recurrence, highlighting the need for alternative therapeutic strategies that leverage gut microbiota.
• What they did: Researchers isolated and characterized CGMCC 17111, a genetically distinct Streptomyces species from the human gut, demonstrating its anticancer activity in both in vitro and in vivo models.
• The result: The findings suggest that gut microbiota like CGMCC 17111 may influence tumor-related processes and could serve as a foundation for developing microbiota-based cancer therapies that maintain host homeostasis.